ScholarMate
English简体中文繁體中文
Customer service: 400-1616-289
Sign inSign up
Journal article

Fibrinogen-to-Albumin Ratio and Long-Term Mortality in Coronary Artery Disease Patients with Different Glucose Metabolism Status

Xie, Yun; Xu, Xiayan; Wang, Dongmei; Zhou, Yang; Kang, Yu; Lai, Wenguang; Lu, Hongyu; Liu, Jin; Chen, Shiqun; Xu, Junyan; Yan, Xiaoming*; Huang, Xiaoyu*; Liu, Yong*广东省人民医院; 广东省心血管病研究所; 南方医科大学; 汕头大学; y
Reviews in Cardiovascular Medicine2023-11DOI: 10.31083/j.rcm2411317
9Reads
CiteSave
Share

Abstract

Background: Abnormal glucose metabolism is present in most patients with coronary artery disease (CAD). Inflammation is considered to be a common risk factor for CAD and diabetes. Fibrinogen-to-albumin ratio (FAR), a novel inflammation biomarker, has been proposed as a predictor for cardiovascular disease. However, the relationship between the level of FAR and long-term mortality including all-cause, cardiovascular and cancer mortality, remains unknown in CAD patients, especially those with prediabetes. Methods: We enrolled 66,761 CAD patients from 2007 to 2020 from a multi-center registry cohort study. The primary outcomes were the all-cause, cardiovascular and cancer mortality. FAR was calculated using the following formula: Fibrinogen (g/L)/Albumin (g/L). Patients were divided into three groups by FAR tertile (low FAR (FAR-L), median FAR (FAR-M), high FAR (FAR-H)), and further categorized into 9 groups according to FAR and glucose metabolism status (normal glucose regulation (NGR), prediabetes mellitus (PreDM), diabetes mellitus (DM)). Cox regression models and competing risk models were used to examine the relationships between FAR and clinical outcomes. Results: 66,761 patients (63.1 +/- 11.0 years, 75.3% male) were enrolled. During the follow-up, 10,534 patients died, including 4991 cardiovascular deaths and 1092 cancer deaths. After adjusting for confounders, higher FAR was associated with increased risk of all -cause and cause-specific mortality in CAD patients with NGR, PreDM and DM. The risk of all-cause and cardiovascular mortality was highest in FAR-H with DM (HR (95% CI) = 1.71 (1.58-1.86), 2.11 (1.86-2.38), respectively; p < 0.001). FAR-H with PreDM was significantly associated with the highest risk of cancer mortality (HR (95% CI) = 2.27 (1.70-3.02), p < 0.001). Adding FAR to the original model significantly improved the prediction of long-term mortality. Conclusions: Increased FAR was significantly associated with higher risk of all-cause and cause-specific mortality in CAD patients with NGR, PreDM and DM. Abnormal glucose metabolism augments the relationship between FAR and mortality. Clinical Trial Registration: ClinicalTrials.gov NCT05050877.

Disciplines and keywords

Keywords
fibrinogen -to -albumin ratiodiabetesprediabeteslong-term mortalitycoronary artery disease
Related
Loading…
  • Association Between Systemic Immune Inflammation Level and Poor Prognosis Across Different Glucose Metabolism Status in Coronary Artery Disease Patients
    Xu, Xiayan; Xie, Yun; Gu, Xia; Zhou, Yang; Kang, Yu; Liu, Jin; Lai, Wenguang; Lu, Hongyu; Chen, Shiqun; Xu, Jun-yan; Lin, Feng*; Liu, Yong*Journal of Inflammation Research, 2023, 16: 4031-4042.
  • Hyperglycemia newly detected by glycated hemoglobin affects all-cause mortality in coronary artery disease patients: a retrospective cohort study
    Wei, Wen; Liang, Yan; Guo, Dachuan; Xu, Xinghao; Xu, Qingbo; Li, Shanggang; Li, Yuqi; Liu, Jin; Liu, Yong; Tu, Mei; Chen, Kaihong*; Chen, Hong*; Chen, Shiqun*Diabetes Research and Clinical Practice, 2022, 191: 110053.Cited by 3
  • The U-Shape Relationship Between Glycated Hemoglobin Level and Long-Term All-Cause Mortality Among Patients With Coronary Artery Disease
    Liu, Liwei; Ye, Jianfeng; Ying, Ming; Li, Qiang; Chen, Shiqun; Wang, Bo; Lin, Yihang; Chen, Guanzhong; Lun, Zhubin; Huang, Haozhang; Li, Huangqiang; Xu, Danyuan; Tan, Ning; Chen, Jiyan; Liu, Jin*; Liu, Yong*Frontiers in Cardiovascular Medicine, 2021, 8: 632704.Cited by 6
View all →

Publication info

Publication status
Published
Journal
Reviews in Cardiovascular Medicine
Publication date
2023-11
Volume / issue
Vol. 24, Issue 11
Pages
317
DOI
10.31083/j.rcm2411317
Language
ENGLISH
Output indexing
SCIE
Funding acknowledgment
Guangdong Provincial science and technology project [2020B1111170011, DFJH2020026, DFJH201919, KJ022021049]; National Science Foundation for Young Scientist of China [82070360]

Authors

  • X

    Xie, Yun (First author)

    guangdong cardiovasc inst · guangdong prov peoples hosp · southern med univ

  • X

    Xu, Xiayan

    guangdong cardiovasc inst · guangdong prov peoples hosp · southern med univ

View all 13 authorsShow fewer authors
  • W

    Wang, Dongmei

    guangdong prov peoples hosp

  • Z

    Zhou, Yang

    guangdong cardiovasc inst · guangdong prov peoples hosp · southern med univ

  • K

    Kang, Yu

    shantou univ · guangdong cardiovasc inst · guangdong prov peoples hosp · southern med univ

  • L

    Lai, Wenguang

    guangdong cardiovasc inst · guangdong prov peoples hosp · southern med univ

  • L

    Lu, Hongyu

    guangdong cardiovasc inst · guangdong prov peoples hosp · southern med univ

  • L

    Liu, Jin

    guangdong cardiovasc inst · guangdong prov peoples hosp · southern med univ

  • C

    Chen, Shiqun

    guangdong cardiovasc inst · guangdong prov peoples hosp · southern med univ

  • X

    Xu, Junyan

    guangdong cardiovasc inst · guangdong prov peoples hosp · southern med univ

  • Y

    Yan, Xiaoming (Corresponding)

    guangdong prov peoples hosp · southern med univ

  • H

    Huang, Xiaoyu (Corresponding)

  • L

    Liu, Yong (Corresponding)

    guangdong cardiovasc inst · guangdong prov peoples hosp · southern med univ

Sign in for more features

  • Save this paper in My collections
  • Claim your outputs and generate promotion materials
  • Follow authors for new outputs
  • Join groups and collaborate
Sign up / Sign in

Products

  • ScholarMate
  • InnoCity
  • IRISaaS

Support

  • Help Center
  • Privacy Policy
  • Terms of Service

Contact

Online support: []
Customer service: 400-1616-289
Email: support@scholarmate.com

Follow or download ScholarMate

WeChat QR code
WeChat official account
App download QR code
Download the app
OutputsResearchersResearch institutionsResearch newsIRISaaS

©2026 深圳市科研之友网络服务有限公司

Public security registration badge粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417